AIM2-derived decapeptide

• Description:

  AIM2-derived decapeptide is an AIM2-derived decapeptide and HLA-A1-restricted T-cell epitope. AIM2-derived decapeptide can be used in the research of melanoma[1].

• UNSPSC:

  12352209

• Target:

  AIM2; MHC

• Related Pathways:

  Immunology/Inflammation

• Field of Research:

  Cancer

• Smiles:

  O=C(N[C@@H](CO)C(N[C@@H](CC(O)=O)C(N[C@@H](CO)C(NCC(N[C@@H](CCC(N)=O)C(N[C@@H](CCC(N)=O)C(N[C@@H](C)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC1=CC=C(C=C1)O)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CCCNC(N)=N)N

• Molecular Formula:

  C46H74N18O18

• Molecular Weight:

  1167.19

• References & Citations:

  [1]Andersen RS, et al. High frequency of T cells specific for cryptic epitopes in melanoma patients. Oncoimmunology. 2013 Jul 1;2 (7) :e25374.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Peptides

• Clinical Information:

  No Development Reported

• CAS Number:

  [406478-23-7]